Effect of Bicalutamide Combined with Docetaxel on Serum PSA and VEGF Levels in Patients with Advanced Prostate Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Disease Markers"
DOI: 10.1155/2022/4506350
Abstract: Objective To investigate the effect of bicalutamide combined with docetaxel on the levels of prostate-specific antigen (PSA) in serum and vascular endothelial growth factor (VEGF) in patients with advanced prostate carcinoma (PCa). Methods The clinical… read more here.
Keywords: bicalutamide combined; patients advanced; combined docetaxel; group ... See more keywords
The open, multicenters, double-arms, randomized, parallel controlled clinical trial of lobaplatin or gemcitabine combined with docetaxel as second-line therapy for advanced osteosarcoma-the effectiveness and safety analysis.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.e22506
Abstract: e22506Background: to study the progression free survival (PFS), objective response rate (ORR), overall survival (OS) and safety of lobaplatin or gemcitabine combined with docetaxel as second-line t... read more here.
Keywords: lobaplatin gemcitabine; combined docetaxel; docetaxel second; safety ... See more keywords
Phase I study of apatinib combined with docetaxel in EGFR-negative advanced non-small cell lung cancer (NSCLC).
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.15_suppl.e21184
Abstract: e21184Background: Chemotherapy combined with antiangiogenic agents such as bevacizumab and ramucirumab has been shown to bring overall survival benefit for advanced NSCLC patients (pts). Apatinib i... read more here.
Keywords: apatinib combined; combined docetaxel; docetaxel egfr; study apatinib ... See more keywords